¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immunological suppression"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® immunological reaction ÇÑ±Û ¸é¿ª¹ÝÀÀ
¼³¸í   
  »ýüÀÇ ¸ö ¾È¿¡¼­ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼­ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â Ã¼³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇϴ ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î Çϴ ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» Ã³¸®Çؼ­ Æ¯ÀÌÀûÀΠÇ׿ø°áÁ¤±â¸¦ °®´Â ºÐÀڷΠ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼­ Ã³¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» Ã³¸®ÇÑ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • burst-suppression
    µ¹¹ßÆÄ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological disease
    ¸é¿ªº´, ¸é¿ªÁúȯ
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological recognition
    ¸é¿ªÀνÄ
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
  • motion artifact suppression technique
    ¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
  • suppression
    1. ¾ïÁ¦, ¾ï¾Ð 2. Á¦°Å 3. ÁøÈ­
  • suppression amblyopia
    ¾ïÁ¦¾à½Ã
  • suppression scotoma
    ¾ïÁ¦¾ÏÁ¡
  • water suppression
    ¹°ºÐÀÚ¾ïÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppression
    ¾ïÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological competence
    ¸é¿ªÀû°Ý¼º
  • immunological disease
    ¸é¿ªÁúȯ
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunological recognition
    ¸é¿ªÀÎÁö
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
  • suppression amblyopia
    ¾ïÁ¦¾à½Ã
  • burst-suppression
    µ¹¹ßÆÄ¾ïÁ¦
  • central suppression
    Á߽ɾïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-suppression exercise
    ¾ïÁ¦¹æÁöÈÆ·Ã
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • glucocorticoid suppression test
    ´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • phenotypic suppression
    Ç¥ÇöÇü ¾ïÁ¦
  • immunological
    ¸é¿ªÇÐÀû.
  • immunological
    ¸é¿ªÇÐÀû.
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦.
  • immunological adjuvant
    ¸é¿ªÇÐÀû¾ÆÁÖ¹ÝÆ®
  • immunological adsorbent
    ¸é¿ªÈíÂøÁ¦.
  • immunological competence
    ¸é¿ª´É·Â(¡­Òöæ³).
  • immunological competence
    ¸é¿ª´É·Â(¡­Òöæ³).
  • immunological deficiency state
    ¸é¿ª°áÇÌ »óÅÂ.
  • immunological disease =immunopathy
    ¸é¿ªÁúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-suppression exercise
    ¾ïÁ¦¹æÁöÈÆ·Ã
  • burst suppression
    °¨Á¤¾ï¾Ð
  • central suppression
    Á߽ɾïÁ¦
  • deoxyuridine suppression test
    µ¥¿Á½Ã¿ì¸®µò¾ïÁ¦½ÃÇè
  • dexamethasone suppression test
    µ¦»ç¸ÞŸÁ¸¾ïÁ¦½ÃÇè
  • dust suppression
    ¸ÕÁö¹ß»ý¾ïÁ¦.
  • facultative suppression
    ÀӽþïÁ¦
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • glucocorticoid suppression test
    ´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
  • magnetization transfer suppression
    ÀÚÈ­ Àü´Þ ¾ïÁ¦
  • motion artifact suppression technique
    ¿îµ¿ Àΰø À½¿µ ¾ïÁ¦¼ú
  • obligatory suppression
    ºÒº¯¾ïÁ¦
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological suppression
    ¸é¿ª ¾ï¾Ð(Øóæ¹åääâ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological competence
    ¸é¿ª´É(Øóæ¹Òö)
  • immunological enhancement
    ¸é¿ª Áõ°­(Øóæ¹ñòË­)
  • immunological equivalence
    ¸é¿ª ´ç·®(Øóæ¹Ó×Õá)
  • immunological inhibition
    ¸é¿ª ÀúÇØ(Øóæ¹îÁúª)
  • immunological paralysis
    ¸é¿ª ¸¶ºñ(Øóæ¹Ø«Ýö)
  • immunological rejection
    ¸é¿ª °ÅºÎ(Øóæ¹ËÞÜú)
  • immunological surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • immunological tolerance
    ¸é¿ª ³»¼º(Øóæ¹Ò±àõ)
  • immunological unresponsiveness
    ¸é¿ª ¹«´ëÀÀ(Øóæ¹ÙíÓßëë)
  • allotype suppression
    µ¿Á¾ÀÌÇü¾ï¾Ð(ÔÒðúì¶úþåääâ)
  • external suppression
    ¿ÜºÎ ¾ï¾Ð(èâÝ»åääâ)
  • extracistronic suppression
    ½Ã½ºÆ®·Ð¿Ü(èâ) ¾ï¾Ð(åääâ)
  • extragenic suppression
    ¿Ü·¡ ¾ï¾Ð (èâÕÎåääâ)
  • frameshift suppression
    ƲÀ̵¿(ì¹ÔÑ) ¾ï¾Ð(åääâ)
  • idiotype suppression
    °³Ã¼Æ¯ÀÌÇü ¾ï¾Ð(ËÁô÷÷åì¶úþåääâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fat suppression
    Áö¹æ¾ïÁ¦
  • frequency selective fat suppression technique
    Á֯ļö¼±Åà Áö¹æ¾ïÁ¦(±â)¹ý
  • magnetization transfer suppression
    ÀÚÈ­Àü´Þ¾ïÁ¦
  • motion artifact suppression technique
    ¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
  • phase evolution of fat suppression
    À§»ó¼±È¸ Áö¹æ¾ïÁ¦
  • suppression
    ¾ïÁ¦, ¾ï¾Ð
  • water suppression
    ¹°ºÐÀÚ¾ïÁ¦
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IT immunological test; immunotherapy; implantation test; individual therapy; information technology; in...
DST   1) Donor Specific Transfusion
  2) Dexamethasone Suppression Test
CAST calpastatin; Cardiac Arrhythmia Suppression Trial; Children of Alcoholism Screening Test
DST desensitization test; dexamethasone suppression test; dihydrostreptomycin; disproportionate septal t...
HTS head traumatic syndrome; HeLa tumor suppression; human thyroid-stimulating hormone, human thyroid st...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
R.I.A. radio-immunological assay
CAST Cardiac Arrhythmia Suppression Trial
CISS Chromosomal in situ suppression
CSD Conditioned Suppression of Drinking
DSI Depolarisation-induced suppression of inhibition
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • immunological
    ¸é¿ªÇÐÀû
    ¸é¿ªÇп¡ °üÇÑ.
  • immunological deficiency state
    ¸é¿ª °áÇÌ »óÅÂ
  • immunological enhancement
    ¸é¿ª Áõ°­ Çö»ó, ¸é¿ª Áõ°­
    ¸é¿ª ¹ÝÀÀÀÇ ¼öÁØÀ» Áõ´ë½ÃŰ´Â ¿©·¯ °¡Áö ƯÀÌÀû ¶Ç´Â ºñƯÀÌÀû »óȲ.
  • immunological incompetence
    ¸é¿ª ºÎÀü
  • immunological paralysis
    ¸é¿ª ¸¶ºñ, ¸é¿ª °ü¿ë
    ´Ù·®ÀÇ Ç׿ø Åõ¿©¿¡ ÀÇÇÏ¿© ¸é¿ªÇÐÀû ¹ÝÀÀÀÌ ¼Ò½ÇµÈ »óÅÂ.
  • immunological resistance
    ¸é¿ª ÀúÇ×
  • immunological tolerance
    ¸é¿ª ³»¼º
    ´Ù¸¥ »óÅ¿¡¼­´Â ü¾×¼º ¶Ç´Â ¼¼Æ÷ ¸Å°³ ¸é¿ªÀ» À¯¹ßÇÒ ¼ö Àִ ƯÁ¤ÀÇ Ç׿ø¿¡ ´ëÇØ¼­, ¸²ÇÁ°è Á¶Á÷ÀÇ Æ¯ÀÌÀû ¹«¹ÝÀÀ¼ºÀÌ ÀϾµµ·Ï µÇ´Â °ÍÀ» Ư¡ÀûÀ¸·Î ÇÏ´Â ¸é¿ª ¹ÝÀÀ.
  • allotype suppression
    ¾Ë·Î ŸÀÔ ¾ïÁ¦
    ÀÓ½ÅÁßÀÎ ¸ðü ¾È¿¡ ºÎÄ£ÀÇ alloty
  • bone marrow suppression
    °ñ¼ö ¾ïÁ¦
  • central suppression
    ÁßÃß¼º ¾ïÁ¦, Á᫐ ¾ïÁ¦
  • dexamethasone suppression test
    µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦ Å×½ºÆ®, µ¦»ç¸ÞŸ¼Õ ¾ï¾Ð ½ÃÇè, µ¦»ç¸ÞŸ¼Õ ¾ïÁ¦ °Ë»ç
  • dust suppression
    ¸ÕÁö ¹ß»ý ¾ïÁ¦
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    ÁÖÆÄ ¼ö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý, Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý
  • motion artifact suppression technique
    ¿îµ¿ Àΰø À½¿µ ¾ïÁ¦¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
models, immunological Theoretical representations that simulate the behaviour or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.
(12 Dec 1998)
immunological Pertaining to immunology.
(18 Nov 1997)
immunological competence <immunology> The bodys ability to develop an immune response to infection or disease. Immunocompetence is measured to see how well the body can fight off certain disease. Many cancer patients become immunocompromised, where their immune system is not as strong as a healthy person's.
(16 Dec 1997)
immunological deficiency Inabillity to mount a normal immune response. Immunodeficiency can be due to a genetic disease or acquired as in aids due to HIV.
(12 Dec 1998)
immunological disease <immunology> Any illness, such as an allergy, that is caused by the action of antibodies.
(09 Oct 1997)
immunological enhancement In immunology, the potentiating effect of specific antibody in establishing and in delaying rejection of a tumour allograft; aside from antibody, non-specific substances may also act to enhance immune response.
Synonym: immunological enhancement.
(05 Mar 2000)
immunological mechanism The groups of cells (chiefly lymphocytes and cells of the reticuloendothelial system) that function in establishing active acquired immunity (induced sensitivity, allergy).
(05 Mar 2000)
immunological memory <immunology> The systems responsible for the situation where reactions to a second or subsequent exposure to an antigen are more extensive than those seen on first exposure (but See immunological tolerance.
The memory is best explained by clonal expansion and persistence of such clones following the first exposure to antigen.
(18 Nov 1997)
immunological network <immunology> The concept due to Jerne that the entire specific immune system within an animal is made up of a series of interacting molecules and cell surface receptors, based on the idea that every antibody combining site carries its own marker antigens or idiotypes and that these in turn may be recognised by another set of antibody combining sites and so on.
(18 Nov 1997)
immunological paralysis Lack of specific antibody production after exposure to large doses of the antigen; immunological paralysis disappears when the antigen is eliminated.
See: immunologic tolerance.
(05 Mar 2000)
immunological surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
immunological tolerance <immunology> Specific unresponsiveness to antigen. Self tolerance is a process occurring normally early in life due to suppression of self reactive lymphocyte clones.
Tolerance to foreign antigens can be induced in adult life by exposure to antigens under conditions in which specific clones are suppressed. Note that tolerance is not the same as immunological unresponsiveness, since the latter may be very non-specific as in immunodeficiency states.
(18 Nov 1997)
ACTH suppression test <investigation> A test that measures the response of the adrenal glands to ACTH.
In this case, dexamethasone is given to the patient and then blood cortisol levels are measured. Under normal conditions, cortisol levels should drop in response to dexamethasone.
In this test one milligram of dexamethasone is administered in the morning and then the blood is drawn for analysis the following morning.
Abnormal test results can indicate Cushing's syndrome.
(27 Sep 1997)
bone marrow suppression <oncology, pharmacology> A side effect of many anticancer and antiviral drugs, including AZT.
Bone marrow suppression leads to a decrease in white blood cells, red blood cells and platelets. Such reductions in turn result in anaemia, bacterial infections and spontaneous or excess bleeding.
(09 Oct 1997)
growth hormone suppression test <investigation> A test to determine if growth hormone is suppressed by hyperglycaemia. Growth hormone blood levels are determined sequentially after ingestion of a glucose-rich meal. If growth hormone levels remain elevated (after the glucose is given) then acromegaly or gigantism is suspected.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppression
    ¾ï¾Ð
  • suppression
    ¾ïÁ¦;Áø¾Ð;¹ß¸Å ±ÝÁö;»èÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á